Role of Topical Steroid Injection With Refractory Benign Esophageal Stricture Endoscopic Dilatation in Children
Recruiting
N/A
Interventional Study
Pediatric Disorder
Esophageal Diseases
Esophageal Stricture
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 2 – 14
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 21 (estimated)
- Sponsor
- Mohammad Daboos · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This clinical trial study included 21 children with refractory benign esophageal strictures. Upper GI endoscopy performed up to the area of stricture, esophageal dilatation done, endoscopy repeated, and steroid injected intralesional under direct endoscopic vision. The effect of the procedure was followed over a period of 12 months by evaluation of number of dilatation, maximum dilator size, perio…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Pediatric patients aged less than 14 years
* with refractory benign esophageal strictures
* received a dilatation therapy without triamcinolone injections
Exclusion Criteria:
* failure to pass a guide wire secondary to pharyngeal stenosis
* tracheo-esophageal fistula
* those…
Contacts